Skip to content

EFFECT OF LETROZOLE PRETREATMENT WITH MISOPROSTOL FOR INDUCTION OF MEDICAL ABORTION (RCT)

EFFECT OF LETROZOLE PRETREATMENT WITH MISOPROSTOL FOR INDUCTION OF MEDICAL ABORTION (RCT)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202211736758845
Enrollment
220
Registered
2022-11-10
Start date
2014-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

induction of abortion

Interventions

misoprostol

Sponsors

ain shams univeristy
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women were considered eligible to participate in the study if they were pregnant with gestational age of 13 weeks or less of missed abortion as confirmed by ultrasound scanning on day 1 of the study, in good general medical condition, and their age is between 20 – 40 years old were accepted

Exclusion criteria

Exclusion criteria: The study excluded women having living fetus, smokers, who gave history of bronchial asthma, IHD, liver or kidney diseases, and those who were receiving regular drug intake before admission to the study except medications for DM, HTN, SLE were accepted.)

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be the abortion rate at 24 h which is defined as the percentage of women with complete expulsion of uterine content ( Passage of the missed abortion through the vagina ) confirmed by ultrasound examination

Secondary

MeasureTime frame
The secondary outcome measures will be the induction-to-abortion interval , the incidence of appearance of side effects ( nausea , vomiting , diarrhea , dizziness , headache , fatigue , fever >38 , breast tenderness , chills , rigors ) , the incidence of postpartum hemorrhage , and occurrence of incomplete abortion .

Countries

Egypt

Contacts

Public Contactahmed abdel wahab

ass prof

ahmedgyna@yahoo.com00966564820942

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026